Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment?

Pharmacogenomics - 1 Aug 2013

Chan Lai Fong, Zai Clement, Monda Marcellino, Potkin Steven, Kennedy James L, Remington Gary, Lieberman Jeffrey, Meltzer Herbert Y, De Luca Vincenzo

Abstract excerpt

AIM: This study explored the role of self-reported ethnicity and genetic ancestry on antipsychotic (AP)-induced weight gain and tardive dyskinesia (TD) in schizophrenia. PATIENTS & METHODS: Ethnicity was determined by self-report as well as Structure analysis of 190 SNPs selected from HapMap3, ge...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Black or African American
Share to Ethnicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene-Environment Interaction

Share to HapMap Project

Share to Movement Disorders

Share to Schizophrenia

Share to Weight Gain

Source

Identifiers

PMID: 23930674
DOI: 10.2217/pgs.13.127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23930674-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment?PMID 23930674Read ↗

A meta-analysis of potential genetic factors associated with antipsychotic-induced weight gain in adults with severe mental illness.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Semantic proximity Read ↗

Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.Semantic proximity Read ↗

A pharmacogenomic study revealed an association between SLC6A4 and risperidone-induced weight gain in Chinese Han population.Semantic proximity Read ↗

Genetics of antipsychotic-induced weight gain: update and current perspectives.Semantic proximity Read ↗

Genomic and transcriptomic insights into antipsychotic-induced changes in total cholesterol and body mass index in a multi-ancestry cohort of the US veteransSemantic proximity Read ↗

Pharmacogenetic Study of Antipsychotic-Induced Lipid and BMI Changes in Chinese Schizophrenia Patients: A Genome-Wide Association StudySemantic proximity Read ↗

Pharmacogenetic study of antipsychotic–induced lipid and BMI changes in Chinese schizophrenia patients: A Genome-Wide Association StudySemantic proximity Read ↗

Genetics of antipsychotic treatment emergent weight gain in schizophrenia.Semantic proximity Read ↗

Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.Semantic proximity Read ↗

Pharmacogenetics of antipsychotics: recent progress and methodological issuesSemantic proximity Read ↗

Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.